deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT02486601

NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma (FOXAGAST)

Phase II Study of NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma

Sponsor: Celgene Corporation

Conditions Cancer of Stomach
Interventions FOLFOX nab-paclitaxel
Updated 9 times since 2017 Last updated: Feb 26, 2019 Started: Jun 30, 2015 Primary completion: Oct 31, 2017 Completion: Jun 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cancer of Stomach and is currently ongoing. Celgene Corporation leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jan 2018 · 12 months · monthly snapshotRecruiting~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2022 · 18 months · monthly snapshotRecruiting~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 12 months · monthly snapshotUnknown

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Jul 2022 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  5. Jan 2021 — Jul 2022 [monthly]

    Recruiting PHASE2

▶ Show 4 earlier versions

  1. Mar 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

  2. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  3. Jan 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  4. Jan 2017 — Jan 2018 [monthly]

    Recruiting PHASE2

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Celgene Corporation
  • GERCOR - Multidisciplinary Oncology Cooperative Group
Data source: GERCOR - Multidisciplinary Oncology Cooperative Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations